• Dr. Li graduated from China Medical University with a M.D. degree and from Yamaguchi University with a Ph.D. degree in 2005. He completed his postdoctoral training in the University of Alabama at Birmingham and was appointed as Instructor in the Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine in 2014.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2022 Fibrinogen mediates cadmium-induced macrophage activation and serves as a predictor of cadmium exposure in chronic obstructive pulmonary disease 2022
    2021 NETosis in the pathogenesis of acute lung injury following cutaneous chemical burnsJCI Insight.  6. 2021
    2021 Citrullinated vimentin mediates development and progression of lung fibrosisScience Translational Medicine.  13. 2021
    2019 Fc receptor-like 2 (FCRL2) is a novel marker of low-risk CLL and refines prognostication based on IGHV mutation statusBlood Cancer Journal.  9. 2019
    2019 Vimentin intermediate filament assembly regulates fibroblast invasion in fibrogenic lung injuryJCI Insight.  4. 2019
    2017 Autoimmunity to vimentin is associated with outcomes of patients with idiopathic pulmonary fibrosisJournal of Immunology.  199:1596-1605. 2017
    2017 Low-dose cadmium exposure induces peribronchiolar fibrosis through site-specific phosphorylation of vimentin 2017
    2016 Attenuated heme oxygenase-1 responses predispose the elderly to pulmonary nontuberculous mycobacterial infections 2016
    2015 Heme oxygenase-1 protects Corexit 9500ainduced respiratory epithelial injury across speciesPLoS One.  10. 2015
    2014 Emerging roles for the FCRL family members in lymphocyte biology and diseaseCurrent Topics in Microbiology and Immunology.  382:29-50. 2014
    2013 FCRL3 promotes TLR9-induced B-cell activation and suppresses plasma cell differentiationEuropean Journal of Immunology.  43:2980-2992. 2013
    2011 Enhanced levels of both the membrane-bound and soluble forms of IgM Fc receptor (FcμR) in patients with chronic lymphocytic leukemiaBlood.  118:4902-4909. 2011
    2008 FCRL6 distinguishes mature cytotoxic lymphocytes and is upregulated in patients with B-cell chronic lymphocytic leukemiaEuropean Journal of Immunology.  38:3159-3166. 2008
    2008 FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemiaBlood.  112:179-187. 2008


    Year Title Altmetric
    2014 Emerging roles for the FCRL family members in lymphocyte biology and disease.  Ed. 382.  2014

    Research Overview

  • Dr. Li researches heavy metals-induced lung fibrosis; Reactive Oxygen Species (ROS), free radical, antioxidants, antioxidase, lipid peroxidation, and diseases; The molecular mechanisms of apoptosis; Toxicology of environmental and occupational toxicants; Epidemiology of cancer and Chronic Obstructive Pulmonary Disease (COPD);The signal transduction mechanisms of immunoreceptors; Fc receptor-like (FCRL) and Fc receptor for IgM expression and biological potential.
  • Education And Training

  • University of Alabama at Birmingham, Postdoctoral Research
  • Doctor of Philosophy in Immunology, Yamaguchi University 2005
  • Doctor of Medicine, China Medical University 1997
  • Master of Public Health, China Medical University 1997
  • Full Name

  • Fu Jun Li